SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-140487
Filing Date
2021-04-29
Accepted
2021-04-29 16:19:10
Documents
15
Period of Report
2021-04-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d98558d8k.htm   iXBRL 8-K 26621
2 EX-99.1 d98558dex991.htm EX-99.1 45688
7 GRAPHIC g98558g0429005006085.jpg GRAPHIC 3726
  Complete submission text file 0001193125-21-140487.txt   236913

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20210429.xsd EX-101.SCH 3792
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ccxi-20210429_def.xml EX-101.DEF 12939
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20210429_lab.xml EX-101.LAB 21223
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20210429_pre.xml EX-101.PRE 13805
8 EXTRACTED XBRL INSTANCE DOCUMENT d98558d8k_htm.xml XML 4373
Mailing Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35420 | Film No.: 21870913
SIC: 2834 Pharmaceutical Preparations